William Febbo, CEO & Director, OptimizeRx [NASDAQ:OPRX]
The business’s new platform enables unparalleled transparency into patient medication behavior along with offering access to patient-provider-pharma communication across the care field and in a range of care settings.
FREMONT, CA: In a recent development, OptimizeRx, a premier of digital health solutions for life science enterprises and payers, has sealed an important business deal for 12 months of admission to its platform and key set of solutions.
“We are excited at our client’s receptivity to enterprise engagements with our platform as we have integrated all of our existing and new offerings onto a single platform with touchpoints throughout the care journey,” said OptimizeRx Chief Commercial Officer Steve Silvestro.
“This comprehensive solution further lowers the barriers that have prevented providers and healthcare consumers from achieving the best possible care outcomes. Additionally, we are seeing very strong performance results for our clients stemming from improved interoperability between our point-of-care and direct-to-patient communications, all working together to deliver improved outcomes.”
Featured in Healthcare Tech Outlook’s “Top 10 Healthcare Communication Solution Providers – 2019,” OptimizeRx’s new platform enables unparalleled transparency into patient medication behavior along with offering access to patient-provider-pharma communication across the care field and in a range of care settings. Healthcare providers and payers and pharmaceutical companies can efficiently address patient medication affordability and therapeutic adherence.
“As we discussed in the last earnings call,” continued Silvestro, “we have a strong pipeline of opportunities, and this enterprise deal is the first of a few deals we’ll announce, which bring us back to the high growth expected from our emerging growth company.”
The platform is integrated in the workflows of some Electronic Health Record (EHR) platforms in ambulatory environments and a burgeoning number of health systems and hospitals. Organizations can deliver patient support and appropriate brand engagement beyond e-couponing during initial stages of the patient’s journey to promote adherence and better results.
With the platform’s intelligent incorporation of real-time communication and data, life science businesses can align messaging to particular kinds of providers and patient populations. The instance helps in offering greater transparency and reaches patients at the point-of-care and beyond effectively.
Commenting on the deal which optimizes the business greatly, Will Febbo, CEO of OptimizeRx, said “This is a major milestone for our company, and it reflects the increasing interest by our clients for enterprise deals that provide access to our now fully-integrated communications platform. As we continue to address the industry need for greater stakeholder collaboration across the care continuum, with the goal of improving care outcomes in a technology-forward and harmonious way, we are seeing the adoption of our platform exceed our internal projections.”
Additionally, talking about the firm’s unprecedented success, Febbo says, “Our success mantra is working with others who know the healthcare and pharmaceutical industries inside out. It is about creating a collaborative approach where we can work together to achieve favorable outcomes.”